Votrient’s extended licence application ditched
April 1, 2014Sales and Marketing EMA, Europe, GSK, ovarian, votrient kidney cancer
GlaxoSmithKline admits it is ‘disappointed’ after abandoning its attempt to extend kidney cancer drug Votrient’s licence to take in ovarian …
Polyhedra Group appoints Steve Hobbs
April 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing polyhedra group, steve hobbs
Steve Hobbs has been appointed chief business development officer for The Polyhedra Group. Hobbs has over 30 years’ international experience …
UK clinical trials system not working during epidemics
April 1, 2014Research and Development, Sales and Marketing Farrar, clinical trials, epidemics, welcome trust
The new director of medical charity the Wellcome Trust has told a British newspaper that the slow-paced nature of clinical …
Red Door Communications hires Sandie Dinning
April 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Red Door Communications, sandy dinning
Sandie Dinning has joined comms agency Red Door Communications and is to launch a new youth and community engagement offering …
GSK invests £130m in Africa
April 1, 2014Manufacturing and Production, Research and Development, Sales and Marketing Africa, GSK, Nigeria, kenya, rwanda, sub-saharan
GlaxoSmithKline is to invest £130 million in sub-Saharan Africa over the next five years – money which the company says …
Icon to acquire Aptiv Solutions
March 31, 2014Manufacturing and Production Aptiv Solutions, ICON, addplan, manufacturing
Icon has acquired US clinical trial specialists Aptiv Solutions for $143.5 million as it looks to expand its footprint in …
Regeneron to expand manufacturing outside US
March 31, 2014Manufacturing and Production Ireland, Regeneron, dell, irish. manufacturing
Regeneron is to open its first overseas production facility in Limerick, Ireland, after addressing the initial objections of a national …
Survey: free NHS in ‘jeopardy’
March 31, 2014Sales and Marketing Hunt, MPs, NHS, coalition, confederation
A survey commissioned by the NHS Confederation suggests that nearly half of UK MPs believe an NHS which is free …
GSK takes possession of Indonesian consumer healthcare unit
March 31, 2014Manufacturing and Production, Sales and Marketing GSK, Indonesia, bognor, emerging markets, insto, sarasvati
GlaxoSmithKline has acquired full ownership of its Indonesian consumer healthcare business in a transaction which also sees the company divesting …
AstraZeneca and MRC partner for new UK facility
March 31, 2014Research and Development, Sales and Marketing AstraZeneca, Cambridge, MRC, Willetts, silicon fen
AstraZeneca and the Medical Research Council have entered into a ‘ground-breaking’ collaboration aimed at better understanding the mechanisms of human …
Deepak Khanna: the legacy of an outgoing ABPI president
March 31, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deepak Khanna, NHS, VBP, Whitehead, apbi, jonathan emms
You’d be forgiven for thinking that Deepak Khanna, the man who has overseen the activities of the ABPI for the …
Portland Health hires director from Hanover
March 31, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, Portland Health, a bpi, comms
Comms agency Portland Health has appointed Matt Worrall as an associate director who joins the firm from Hanover Communications. Worrall …
Life sciences boost from government
March 31, 2014Research and Development, Sales and Marketing DoH, NHS, UK, government, life sciences, medcity
The UK government is to launch an improved offering for the life sciences sector by combining the functions of the …
Stelara hit by final NICE rejection
March 28, 2014Sales and Marketing Janssen, NICE, UK, arthritis, psoriatic, stelar
In final draft guidance released today NICE says it cannot recommend Janssen’s psoriatic arthritis drug Stelara. Specifically, the pricing watchdog …
UK health report flags weight and dementia risks
March 28, 2014Sales and Marketing Dame Sally Davies, Public Health England, dementia, obesity
A new Department of Health report suggests that being overweight is now the norm in England – and that deafness …
Baxter to split in two next year
March 28, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, baxter, biopharma, gambro
Baxter is taking a plunge into the world of restructuring by splitting into two entities: one which is yet to …
MedCity to launch in April
March 28, 2014Medical Communications, Research and Development, Sales and Marketing Boris Johnson, London, UCL, Wellcome, medcity, medical city
The eagerly anticipated launch of ‘MedCity’ will be announced in April, Pharmafile has learned, as the UK government looks to …
CAP-CMV appoints Albrecht Läufer as chief executive
March 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Albrecht Läufer, CAP-CMV, cevec
Biotech firm CAP-CMV which is a spin-out of CEVEC Pharmaceuticals has appointed industry veteran Dr Albrecht Läufer as its chief …
AstraZeneca opens up research
March 28, 2014Medical Communications, Sales and Marketing AstraZeneca, data, research, transparency, website
AstraZeneca has created a new means of sharing some of its data with scientists, such as its bank of live …
Europe grants Eperzan licence
March 27, 2014Sales and Marketing Bydureon, GSK, diabetes, eperzan, lilly
The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
